Relationship of human rectal aberrant crypt foci and formation of colorectal polyp: One-year following up after polypectomy

Table 1 Clinical characteristics of study participants at year 0

		Number of ACF		P value
	Total	0-3	> 3
No. of subjects	89	41	48
Age (yr)	63.4 ± 11.1	62.6 ± 12.9	64.1 ± 9.5	0.52
Gender (male:female)	61:28:00	28:14:00	33:15:00
Waist Circumference (cm)	85.9 ± 11.5	84.7 ± 8.1	86.7 ± 13.6	0.57
BMI (kg/m2)	23.2 ± 3.1	22.6 ± 2.3	23.8 ± 3.6	0.09
Total cholesterol (mg/dL)	210.7 ± 34.9	208.7 ± 32.6	212.2 ± 36.9	0.69
Triglyceride (mg/dL)	146.2 ± 77.1	125.9 ± 64.1	161.5 ± 83.2	0.06
Hemoglobin A1c (%)	5.9 ± 1.3	5.6 ± 1.2	6.2 ± 1.4	0.13
TFA (cm2)	198.9 ± 95.2	177.0 ± 55.6	215.5 ± 115.2	0.19
VFA (cm2)	90.4 ± 53.5	75.6 ± 41.1	101.6 ± 59.7	0.11
SFA (cm2)	108.5 ± 58.1	101.4 ± 45.7	113.9 ± 66.4	0.49

Data are expressed as mean ± SD. ACF: Aberrant crypt foci; BMI: Body mass index; VFA: Visceral fat area; SFA: Subcutaneous fat area; TFA: Total fat area.

Table 2 Endoscopic results of adenoma at year 0 and year 1

No. of aberrant crypt foci at year 0	0-3	> 3	0-3 vs > 3
No. of subjects	41	48
No. of adenoma at year 0	1.4 ± 1.2	1.6 ± 1.8	0.71
Maximum size of adenoma at year 0	6.0 ± 4.6	6.3 ± 7.2	0.81
No. of adenoma at year 1	1.0 ± 1.0	1.5 ± 1.4	0.08
Maximum size of adenoma at year 1	3.5 ± 3.5	5.5 ± 5.8	0.031

Data are expressed as mean ± SD.

¹P < 0.05.